The laboratory informatics company Sapio Sciences has announced a significant expansion of its partnership with Amazon Web Services (AWS), marking a potential watershed moment in the application of artificial intelligence to drug discovery and development workflows.
A novel integration of protein footprinting and ion mobility mass spectrometry technologies promises to accelerate structural biology research in the biopharmaceutical sector, following a collaboration announced by GenNext Technologies and Agilent.
The Cardiff-based antibody design company Antiverse has secured £3.5 million in additional seed funding, bringing their total equity financing to £7.2 million. The investment round, spearheaded by i&i Biotech Fund I and Kadmos Capital, saw participation from existing investors including InnoSpark Ventures, UKI2S, Tensor Ventures, and AngelHub.
In a significant move to enhance its induced pluripotent stem cell (iPSC) technology portfolio, Axol Bioscience has announced the complete acquisition of French biotechnology firm Phenocell SAS, marking a strategic expansion into ophthalmology and dermatology research models.
Researchers at the University of California San Diego have developed an innovative nanotechnology that can create temporary openings in the nuclear membrane of living cells without damaging the cell’s outer structure. This breakthrough, published in the journal Advanced Functional Materials [1], could revolutionize gene therapy and drug delivery methods by providing direct access to the […]
Researchers from Kindai University and collaborating institutions have achieved a significant milestone in cell biology by creating artificial cell nuclei within living mouse eggs. The study, published in the journal Genes to Cells [1], demonstrates for the first time that functional nuclei can be constructed by injecting purified DNA solution into oocytes, mimicking the fertilisation […]
In a significant advancement for neuroscience, researchers have successfully mapped nearly 140,000 neurons in the brain of a common fruit fly, creating the largest and most complete connectome of an adult animal to date. This groundbreaking work, supported by the U.S. National Institutes of Health (NIH), provides a detailed wiring diagram of the fruit fly […]
In a move towards greater environmental responsibility in the life sciences sector, Greiner Bio-One has announced that its serological pipettes have been awarded the ACT (Accountability, Consistency and Transparency) ecolabel. This certification, granted by the non-profit organisation My Green Lab, represents a significant step in providing scientists and procurement specialists with verified information about the […]
TThe acquisition of Alderley Analytical by Synexa Life Sciences marks a significant development in the bioanalytical services sector. This strategic move, announced on 7 October 2024, aims to broaden Synexa’s capabilities in biomarker and bioanalytical assays, particularly in the areas of mass spectrometry and ligand binding assays.
Cancer Research UK has announced funding of up to £600,000 for a groundbreaking project aimed at developing the world’s first ovarian cancer prevention vaccine. The initiative, led by Professor Ahmed Ahmed at the University of Oxford, seeks to leverage recent advancements in immunology and cancer biology to create a vaccine that could potentially prevent ovarian […]
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
